European Union - English - EMA (European Medicines Agency)

bristol-myers squibb pharma eeig - belatacept - graft rejection; kidney transplantation - immunosuppressants - nulojix, in combination with corticosteroids and a mycophenolic acid (mpa), is indicated for prophylaxis of graft rejection in adult recipients of a renal transplant. 

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - abatacept - powder for solution for infusion - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - belatacept - powder for solution for infusion - 250mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - abatacept - solution for injection - 125mg/1ml

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bristol-myers squibb pharmaceuticals ltd - abatacept - solution for injection - 125mg/1ml

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - benazepril hydrochloride - benazepril hydrochloride 25.9 g/kg - cardiovascular agent

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - benazepril hydrochloride - benazepril hydrochloride 103.62 g/kg - cardiovascular agent

New Zealand - English - Ministry for Primary Industries

zoetis new zealand limited - benazepril hydrochloride - benazepril hydrochloride 25.9 g/kg - cardiovascular agent

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - lisinopril dihydrate - tablets - 10 milligram - lisinopril

Ireland - English - HPRA (Health Products Regulatory Authority)

actavis group ptc ehf - lisinopril dihydrate - tablets - 2.5 milligram - lisinopril